Hipopituitarismo congénito

1. Kliegman R, St Geme J. Nelson Textbook of Pediatrics. 21st ed. Philadelphia, PA: Elsevier; 2020

2. Macdonald MG, Mullet MD, Seshia MMK. Avery’s Neonatology Pathophysiology and Management of the Newborn. 7th ed. Philadelphia, PA: Lippincott. 2016

3. Alatzoglou KS, Dattani MT. Genetic forms of hypopituitarism and their manifestation in the neonatal period. Early Hum Dev. 2009; 85(11):705–712

4. Bosch I Ara L, Katugampola H, Dattani MT. Congenital hypopituitarism during the neonatal period: epidemiology, pathogenesis, therapeutic options, and outcome. Front Pediatr. 2021;8:600962

5. Alatzoglou KS, Gregory LC, Dattani MT. Development of the pituitary gland. Compr Physiol. 2020;10(2):389–413

6. Tziaferi V, Dattani MT. Pituitary gland embryology, anatomy and physiology. In: Ledbetter DJ, Johnson PRV, eds. Endocrine Surgery in Children. New York, NY: Springer; 2018:427–437

7. Davis SW, Ellsworth BS, Perez Millan MI, et al. Pituitary gland development and disease: from stem cell to hormone production. Curr Top Dev Biol. 2013;106:1–47

8. Cohen LE, Radovick S. Molecular basis of combined pituitary hormone deficiencies. Endocr Rev. 2002;23(4):431–442

9.Mehta A, Dattani MT. Developmental disorders of the hypothalamus and pituitary gland associated with congenital hypopituitarism. Best Pract Res Clin Endocrinol Metab. 2008;22(1):191–206

10. Ooi GT, Tawadros N, Escalona RM. Pituitary cell lines and their endocrine applications. Mol Cell Endocrinol. 2004;228(1-2):1–21

11. Sheng HZ, Moriyama K, Yamashita T, et al. Multistep control of pituitary organogenesis. Science. 1997;278(5344):1809–1812

12. Sheng HZ, Westphal H. Early steps in pituitary organogenesis. Trends Genet. 1999;15(6):236–240

13. Martin RJ, Fanaroff AA, Walsh MC. Fanaroff and Martin's Neonatal- Perinatal Medicine: Diseases of the Fetus and Infant. 11th ed. Philadelphia, PA: Elsevier; 2020

14. Dasen JS, Rosenfeld MG. Signaling and transcriptional mechanisms in pituitary development. Annu Rev Neurosci. 2001;24:327–355

15. Zhu X, Gleiberman AS, Rosenfeld MG. Molecular physiology of pituitary development: signaling and transcriptional networks. Physiol Rev. 2007;87(3):933–963

16. Zhu X, Wang J, Ju BG, Rosenfeld MG. Signaling and epigenetic regulation of pituitary development. Curr Opin Cell Biol. 2007; 19(6):605–611

17. Ahmad T, Borchert M, Geffner M. Optic nerve hypoplasia and hypopituitarism. Pediatr Endocrinol Rev. 2008;5(3):772–777

18. Kelberman D, Dattani MT. The role of transcription factors implicated in anterior pituitary development in the aetiology of congenital hypopituitarism. Ann Med. 2006;38(8):560–577

19. Garcia-Filion P, Borchert M. Optic nerve hypoplasia syndrome: a review of the epidemiology and clinical associations. Curr Treat Options Neurol. 2013;15(1):78–89

20. Sataite I, Cudlip S, Jayamohan J, Ganau M. Septo-optic dysplasia. Handb Clin Neurol. 2021;181:51–64

21. Mehta A, Hindmarsh PC, Mehta H, et al. Congenital hypopituitarism: clinical, molecular and neuroradiological correlates. Clin Endocrinol (Oxf). 2009;71(3):376–382

22. Wu ZY, Li YL, Chang B. Pituitary stalk interruption syndrome and liver changes: From clinical features to mechanisms. World J Gastroenterol. 2020;26(44):6909–6922

23. Karaca E, Buyukkaya R, Pehlivan D, et al. Whole-exome sequencing identifies homozygous GPR161 mutation in a family with pituitary stalk interruption syndrome. J Clin Endocrinol Metab. 2015;100(1): E140–E147

24. Balasubramanian R, Choi JH, Francescatto L, et al. Functionally compromised CHD7 alleles in patients with isolated GnRH deficiency. Proc Natl Acad Sci USA. 2014;111(50):17953–17958

25. Balasubramanian R, Crowley WF Jr. Reproductive endocrine phenotypes relating to CHD7 mutations in humans. Am J Med Genet C Semin Med Genet. 2017;175(4):507–515

26.Gregory LC, Gevers EF, Baker J, et al. Structural pituitary abnormalities associated with CHARGE syndrome. J Clin Endocrinol Metab. 2013;98(4):E737–E743

27. Mody S, Brown MR, Parks JS. The spectrum of hypopituitarism caused by PROP1 mutations. Best Pract Res Clin Endocrinol Metab. 2002;16(3):421–431

28. Parkin K, Kapoor R, Bhat R, Greenough A. Genetic causes of hypopituitarism. Arch Med Sci. 2019;16(1):27–33

29.Gregory LC, Dattani MT. The molecular basis of congenital hypopituitarism and related disorders. J Clin Endocrinol Metab. 2020;105(6):dgz184

30. Bonfig W, Krude H, Schmidt H. A novel mutation of LHX3 is associated with combined pituitary hormone deficiency including ACTH deficiency, sensorineural hearing loss, and short neck-a case report and review of the literature. Eur J Pediatr. 2011;170(8): 1017–1021

31. Filges I, Bischof-Renner A, R€othlisberger B, et al. Panhypopituitarism presenting as life-threatening heart failure caused by an inherited microdeletion in 1q25 including LHX4. Pediatrics. 2012;129(2):e529–e534

32. Couture C, Saveanu A, Barlier A, et al. Phenotypic homogeneity and genotypic variability in a large series of congenital isolated ACTH deficiency patients with TPIT gene mutations. J Clin Endocrinol Metab. 2012;97(3):E486–E495

33. Sun Y, Bak B, Schoenmakers N, et al. Loss-of-function mutations in IGSF1 cause an X-linked syndrome of central hypothyroidism and testicular enlargement. Nat Genet. 2012;44(12):1375–1381

34. Mehta S, Brar PC. Severe, persistent neonatal hypoglycemia as a presenting feature in patients with congenital hypopituitarism: a review of our case series. J Pediatr Endocrinol Metab. 2019;32(7): 767–774

35. Piantanida E, Ippolito S, Gallo D, et al. The interplay between thyroid and liver: implications for clinical practice. J Endocrinol Invest. 2020;43(7):885–899